Together, these preclinical findings strongly indicate that ferroptosis is not a secondary consequence of neurodegeneration in AD, but rather functions as an upstream pathogenic mechanism that drives Aβ production, tau hyperphosphorylation, and neuronal apoptosis. Here, MAPT is linked to Alzheimer disease.